# Neurotransmitter Levels in Children With Specific Learning Disorder

> **NCT07240142** · NA · COMPLETED · sponsor: **Dilara Ulger Ozbek** · enrollment: 40 (actual)

## Conditions studied

- Specific Learning Disability
- Healthy (Controls)

## Interventions

- **PROCEDURE:** Blood Product
- **OTHER:** Elisa test

## Key facts

- **NCT ID:** NCT07240142
- **Lead sponsor:** Dilara Ulger Ozbek
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-22
- **Primary completion:** 2020-10-21
- **Final completion:** 2021-04-16
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07240142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07240142, "Neurotransmitter Levels in Children With Specific Learning Disorder". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT07240142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*